Atopic Dermatitis and Cardiovascular Risk in Pediatric Patients: A Systematic Review and Meta-Analysis

Chloe Kern1, Camila Ortiz2, Michael Johanis3

  • 1Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York, USA.

Insights

Childhood atopic dermatitis (AD) shows a potential link to cardiovascular issues, but current evidence is weak. More research is needed to confirm if AD significantly increases heart disease risk in children.

Area of Science:

  • Pediatric Dermatology
  • Cardiovascular Health
  • Inflammatory Diseases

Background:

  • Cardiovascular guidelines advocate for early screening and preventative care in children with chronic inflammatory conditions.
  • Atopic dermatitis (AD) is linked to cardiovascular risk in adults, yet pediatric data remain scarce.
  • Understanding the cardiovascular implications of childhood AD is crucial for preventative strategies.

Purpose of the Study:

  • To systematically review and analyze studies investigating the association between childhood atopic dermatitis and cardiovascular risk factors and outcomes.
  • To synthesize current evidence on the link between AD in children and conditions like ischemic heart disease, diabetes, and lipid disorders.

Main Methods:

  • A systematic literature search was conducted to identify relevant studies.
  • Data from 10 publications, encompassing 577,148 individuals, were analyzed.
  • GRADE assessments were used to evaluate the certainty of evidence.

Main Results:

  • Initial analysis suggested associations between AD and ischemic heart disease and diabetes, but these did not persist after adjusting for confounders.
  • An association with lipid disorders was observed, but not consistently across the entire population distribution.
  • No significant association was found between AD and hypertension or stroke.
  • The certainty of evidence was rated as very low to low due to study limitations and lack of detail on AD severity and confounders.

Conclusions:

  • Current evidence does not support a clinically significant increase in cardiovascular risk for children with atopic dermatitis.
  • Limitations in study design, including insufficient detail on AD severity and confounders like body mass index, impact the reliability of findings.
  • Further high-quality research is required to definitively establish the relationship between childhood AD and cardiovascular health.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
15
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
32
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K